| 000 | 01878 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513112314.0 | ||
| 264 | 0 | _c19970415 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.272.9.5792 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSexl, V | |
| 245 | 0 | 0 |
_aStimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cFeb 1997 |
||
| 300 |
_a5792-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a8-Bromo Cyclic Adenosine Monophosphate _xpharmacology |
| 650 | 0 | 4 |
_aAdenosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdenosine-5'-(N-ethylcarboxamide) |
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xenzymology |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xpharmacology |
| 650 | 0 | 4 |
_aErbB Receptors _ximmunology |
| 650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xpharmacology |
| 650 | 0 | 4 |
_aFlavonoids _xpharmacology |
| 650 | 0 | 4 |
_aGTP-Binding Proteins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoproterenol _xpharmacology |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aReceptors, Purinergic P1 _xmetabolism |
| 650 | 0 | 4 |
_aThymidine _xmetabolism |
| 650 | 0 | 4 |
_aTyrosine _xmetabolism |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 700 | 1 | _aMancusi, G | |
| 700 | 1 | _aHöller, C | |
| 700 | 1 | _aGloria-Maercker, E | |
| 700 | 1 | _aSchütz, W | |
| 700 | 1 | _aFreissmuth, M | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 272 _gno. 9 _gp. 5792-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.272.9.5792 _zAvailable from publisher's website |
| 999 |
_c9026910 _d9026910 |
||